Zobrazeno 1 - 4 of 4 pro vyhledávání: '"Faranak Jamali"'
1
An FDA Analysis of Inspected Entities After Receiving Official Action Indicated Letters for Good Clinical Practice Violations
Autor: Michelle S Anantha, Miah Jung, Rachelle M Swann, Faranak Jamali
Publikováno v: Therapeutic Innovation & Regulatory Science
Background Limited research has been conducted to examine whether clinical investigators (CIs), sponsors (SPs), contract research organizations (CROs), and sponsor-investigators (SIs) continue conducting clinical trials following issuance of FDA Offi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa57f6cf241245a8f98f7f44b0aae950
https://doi.org/10.1007/s43441-021-00267-y
Zobrazit plný text záznamu
2
Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura
Autor: Faranak, Jamali, Steven, Lemery, Kassa, Ayalew, Suzanne, Robottom, Kathy, Robie-Suh, Dwaine, Rieves, Richard, Pazdur
Publikováno v: Oncology (Williston Park, N.Y.). 23(8)
On August 22, 2008, Romiplostim (Nplate for Injection) received approval from the US Food and Drug Administration (FDA) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::877c5388f194ff5ddc2d8b903f085d04
https://pubmed.ncbi.nlm.nih.gov/19711587
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje